Zynex Earns Spot on Financial Times List of "The Americas' Fastest-Growing Companies 2023" for Second Consecutive Year

Rhea-AI Summary

Zynex, Inc. (NASDAQ: ZYXI) has been ranked 191 out of 500 on The Financial Times' fourth annual list of The Americas' Fastest Growing Companies 2023. This recognition highlights Zynex's consistent revenue growth, achieving a remarkable 308% increase in revenue and a compound annual growth rate (CAGR) of 60% between 2018 and 2021. CEO Thomas Sandgaard emphasized that this accolade reflects the company's ongoing performance along with 24 other publicly traded companies in the Healthcare & Life Sciences sector. Zynex specializes in non-invasive medical devices for pain management, rehabilitation, and patient monitoring.

Positive

• Ranked 191 out of 500 on The Financial Times' Fastest Growing Companies list.
• Achieved 308% revenue growth and a CAGR of 60% between 2018 and 2021.
• Recognition alongside 24 other public companies in the Healthcare & Life Sciences sector.

Negative

• None.

ENGLEWOOD, Colo., April 6, 2023 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that it has been ranked 191 out of 500 on The Financial Times fourth annual list of The Americas' Fastest Growing Companies 2023.

"Zynex has consistently grown revenue and profitability over the last several years and we are pleased that our performance has been recognized alongside other innovative organizations," said Thomas Sandgaard, CEO and founder of Zynex. "The Company grew revenue by 308% and achieved a compound annual growth rate (CAGR) of 60% between 2018 and 2021, when the data for the rankings was collected. Additionally, we are pleased to be one of twenty-four publicly traded Healthcare & Life Sciences companies recognized in this high growth category."

The full list is available at: The Americas' Fastest Growing Companies 2023

About Zynex, Inc.
Zynex, founded in 1996, develops, manufactures, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis and laser-based pulse oximetry monitoring systems for use in hospitals. For additional information, please visit: www.zynex.com

Contact: Zynex, Inc. (800) 495-6670

Investor Relations Contact:
Gilmartin Group
Investor Relations Counsel
ir@zynex.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/zynex-earns-spot-on-financial-times-list-of-the-americas-fastest-growing-companies-2023-for-second-consecutive-year-301791466.html

SOURCE Zynex

FAQ

What is Zynex's ranking on The Americas' Fastest Growing Companies 2023 list?

Zynex is ranked 191 out of 500 on The Financial Times' list of The Americas' Fastest Growing Companies 2023.

What revenue growth did Zynex achieve from 2018 to 2021?

Zynex achieved a revenue growth of 308% and a compound annual growth rate (CAGR) of 60% from 2018 to 2021.

How many publicly traded healthcare companies were recognized with Zynex in 2023?

Zynex was recognized alongside 24 other publicly traded companies in the Healthcare & Life Sciences sector.

What does Zynex specialize in?

Zynex specializes in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring.